Suppr超能文献

血栓闭塞性脉管炎中调节免疫反应的分子机制:综述

Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review.

作者信息

Shapouri-Moghaddam Abbas, Saeed Modaghegh Mohammad-Hadi, Rahimi Hamid Reza, Ehteshamfar Seyyed-Morteza, Tavakol Afshari Jalil

机构信息

Immunology Research Group, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Vascular and Endovascular Surgery Research Center, Alavi Hospital, Mashhad University of Medical Sciences, Iran.

出版信息

Iran J Basic Med Sci. 2019 Mar;22(3):215-224. doi: 10.22038/ijbms.2019.31119.7513.

Abstract

Thromboangiitis obliterans (TAO) is a thrombotic-occlusive as well as an inflammatory peripheral vascular disease with unknown etiology. Recent evidence has supported the immunopathogenesis of the disease, however, the factors contributing to the altered immune function and vascular tissue inflammation are still unclear. This review was intended to collate the more current knowledge on the regulatory molecules involved in TAO from an immunoreactive perspective. The homeostasis of the immune system as well as a variety of progenitor cell populations appear to be affected during TAO and these alterations are associated with intrinsic signaling defects that are directing to an improved understanding of the crosstalk between angiogenesis and the immune system, as well as the potential of new co-targeting strategies applying both immunotherapy and angiogenic therapy.

摘要

血栓闭塞性脉管炎(TAO)是一种病因不明的血栓闭塞性及炎症性外周血管疾病。最近的证据支持了该疾病的免疫发病机制,然而,导致免疫功能改变和血管组织炎症的因素仍不清楚。本综述旨在从免疫反应的角度整理关于TAO中涉及的调节分子的最新知识。在TAO期间,免疫系统的稳态以及各种祖细胞群体似乎受到影响,这些改变与内在信号缺陷有关,这有助于更好地理解血管生成与免疫系统之间的相互作用,以及应用免疫疗法和血管生成疗法的新联合靶向策略的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76e/6528722/785bb438bffa/IJBMS-22-215-g001.jpg

相似文献

1
Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review.
Iran J Basic Med Sci. 2019 Mar;22(3):215-224. doi: 10.22038/ijbms.2019.31119.7513.
2
Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans.
Curr Med Chem. 2015;22(16):1992-2001. doi: 10.2174/0929867322666150429112111.
5
Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells.
Atherosclerosis. 2017 Oct;265:258-265. doi: 10.1016/j.atherosclerosis.2017.08.009. Epub 2017 Aug 18.
7
Thromboangiitis obliterans (Buerger's disease).
Vasa. 2014 Sep;43(5):337-46. doi: 10.1024/0301-1526/a000371.
8
Alleviation of A disintegrin and metalloprotease 10 (ADAM10) on thromboangiitis obliterans involves the HMGB1/RAGE/ NF-κB pathway.
Biochem Biophys Res Commun. 2018 Oct 20;505(1):282-289. doi: 10.1016/j.bbrc.2018.09.002. Epub 2018 Sep 20.
9
The IL-6/STAT3 pathway regulates adhesion molecules and cytoskeleton of endothelial cells in thromboangiitis obliterans.
Cell Signal. 2018 Apr;44:118-126. doi: 10.1016/j.cellsig.2018.01.015. Epub 2018 Jan 13.

引用本文的文献

1
Exploring the oxidative and inflammatory markers landscape in Buerger's disease: A comparative analysis.
J Educ Health Promot. 2025 Jul 4;14:242. doi: 10.4103/jehp.jehp_146_24. eCollection 2025.
4
Oxidative stress in vascular surgical diseases: mechanisms, impacts and therapeutic perspectives.
Front Pharmacol. 2025 Apr 9;16:1527684. doi: 10.3389/fphar.2025.1527684. eCollection 2025.
5
Comparative Analysis of Transcriptome Profiles in Patients with Thromboangiitis Obliterans.
Genes (Basel). 2023 Dec 21;15(1):19. doi: 10.3390/genes15010019.
6
Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways.
Front Pharmacol. 2022 Oct 11;13:1018438. doi: 10.3389/fphar.2022.1018438. eCollection 2022.
9
Predictive value of serum VEGF, IL-1 and TNF-α in the treatment of thromboangiitis obliterans by revascularization.
Exp Ther Med. 2020 Dec;20(6):232. doi: 10.3892/etm.2020.9362. Epub 2020 Oct 16.

本文引用的文献

1
Unexpected Inflammation in the Sympathetic Ganglia in Thromboangiitis Obliterans.
Int J Angiol. 2017 Dec;26(4):212-217. doi: 10.1055/s-0037-1604410. Epub 2017 Jul 27.
5
Increased Serum HMGB-1, ICAM-1 and Metalloproteinase-9 Levels in Buerger's Patients.
Curr Vasc Pharmacol. 2016;14(4):382-7. doi: 10.2174/1570161114666160303111355.
6
Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx.
J Diabetes Complications. 2016 May-Jun;30(4):563-72. doi: 10.1016/j.jdiacomp.2016.01.014. Epub 2016 Jan 22.
7
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney.
Kidney Res Clin Pract. 2015 Dec;34(4):194-200. doi: 10.1016/j.krcp.2015.10.004. Epub 2015 Nov 12.
8
Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation.
Allergol Int. 2016 Jan;65(1):21-9. doi: 10.1016/j.alit.2015.08.001. Epub 2015 Sep 9.
9
IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms.
Vascul Pharmacol. 2015 Oct;73:57-63. doi: 10.1016/j.vph.2015.07.012. Epub 2015 Jul 29.
10
Angiopoietin-1 inhibits toll-like receptor 4 signalling in cultured endothelial cells: role of miR-146b-5p.
Cardiovasc Res. 2015 Jun 1;106(3):465-77. doi: 10.1093/cvr/cvv120. Epub 2015 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验